Innovating Works

AZULINDUS Y MARTI

Activa
ImmunoFit: Harnessing tumor metabolism to overcome immunosupression VIB VZW tramitó un H2020: ERC-2017-COG Anti-cancer immunotherapy has provided patients with a promising treatment. Yet, it has also unveiled that the immunosuppressive tumor micro...
2018-02-12 - 2024-03-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.